KONJUGAT VON FINASTERID MIT PEPTID

European patent · EP3431505 · In force

Register entry

Publication number
EP3431505
Application number
EP16894653
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 20, 2016
Published
Jan 23, 2019
Granted
Sep 7, 2022
Protection ends at the latest
May 19, 2036
Next annual fee due
May 31, 2027
IPC classes
C07K 19/00 (2006.01)
C07K 7/06 (2006.01)
C07K 7/08 (2006.01)
C07J 73/00 (2006.01)
A61K 31/56 (2006.01)
A61K 47/60 (2017.01)
A61K 8/63 (2006.01)
A61Q 7/00 (2006.01)
A61Q 19/00 (2006.01)
Priority
KR 20160032988 18.03.2016
PCT application
PCT/KR2016/005405 20.05.2016
PCT publication
WO2017/159922 21.09.2017
Filing language
Korean
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  4. Jul 19, 2023

    Change

    Published in Swissreg on 19.07.2023

  5. Jun 1, 2023

    Change

    Published in Swissreg on 01.06.2023

  6. Sep 15, 2022

    Agent entered

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 15.09.2022

  7. Sep 7, 2022

    Granted

    Published in Swissreg on 07.09.2022

Parties

Holder

Caregen Co., Ltd.

46-38 LS-ro 91beon-gil Dongan-gu, Anyang-si, Gyeonggi-do 14119, KR

Agent

MICHELI & CIE SA

122, rue de Genève, CP 61, 1226 Thônex

Inventor

KIM, Eun Mi

Yongin-si Gyeonggi-do 16854, KR

CHUNG, Yong Ji

Seoul 06079, KR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.